Mallinckrodt hit back at Acthar whistleblower, lawsuit claims by Eric Sagonowsky Friday, April 13, 2018 Mallinckrodt is under more scrutiny this week with a whistleblower lawsuit alleging fraud, retaliation and more.
Mallinckrodt foiled Acthar rival to hike prices 85,000%: lawsuit by Eric Sagonowsky Tuesday, October 31, 2017 A set of Medicare payers accuse embattled Mallinckrodt of violating antitrust law to stifle competition for its $1 billion-plus Acthar Gel.
JAMA piece resurrects questions over cost of Mallinckrodt's Acthar by Eric Palmer Wednesday, September 13, 2017 A new study in JAMA has put the focus back on the price of Mallinckrodt's controversial med, H.P. Acthar gel.
